Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer

by Maarten Versteven, Johan M. J. Van den Bergh, Elly Marcq, Evelien L. J. Smits, Evelien L. J. Smits, Evelien L. J. Smits, Viggo F. I. Van Tendeloo, Willemijn Hobo, Eva Lion, Eva Lion
Published 2018-03-01

Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready ‘N Able to Improve Clinical Outcome?

by Yannick Willemen, Maarten Versteven, Marc Peeters, Zwi N. Berneman, Evelien L. J. Smits
Published 2020-01-01

Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity

by Jurjen Tel, Daniel Benitez-Ribas, Edith M. Janssen, Evelien L. J. Smits, Joannes F. M. Jacobs
Published 2016-01-01

Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update

by Yannick Verhoeven, Delphine Quatannens, Xuan Bich Trinh, An Wouters, Evelien L.J. Smits, Filip Lardon, Jorrit De Waele, Peter A. van Dam
Published 2021-02-01

The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3

by Elly Marcq, Jonas R. M. Van Audenaerde, Jorrit De Waele, Céline Merlin, Patrick Pauwels, Jan P. van Meerbeeck, Scott A. Fisher, Evelien L. J. Smits
Published 2021-01-01

Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer

by Laurie Freire Boullosa, Jinthe Van Loenhout, Tal Flieswasser, Jorrit De Waele, Christophe Hermans, Hilde Lambrechts, Bart Cuypers, Kris Laukens, Esther Bartholomeus, Vasiliki Siozopoulou, Winnok H. De Vos, Marc Peeters, Evelien L.J. Smits, Christophe Deben
Published 2021-06-01